Search
Categories


Archive for the ‘Levitra’ Category

US FDA Adding Hearing Loss Risk to Erectile Dysfunction Drug Labels

Monday, May 31st, 2010

U.S. regulators on Thursday said warnings about the risk of sudden hearing loss l inked to drugs for impotence, including Viagra, Cialis, and Levitra, would be added to the drugs’ labels. Reuters Health Information (Source: Medscape Pharmacist Headlines)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

PDE-5 inhibitor safe, effective in hypertensive men

Monday, May 31st, 2010

Munich, Germany—The phosphodiesterase type-5 inhibitor vardenafil hydrochloride
(Levitra) is a safe and effective option in the treatment of erectile dysfunction in men being treated with common
medications for hypertension, researchers report in a recent study published in the Journal of Sexual Medicine
(2005; 2:856-64). Both hypertension and the drugs used to treat it have been known to adversely affect erectile
f unction. (Source: (more…)

ED Drugs Prove Effective, Safe For Men With Diabetes

Monday, May 31st, 2010

Popular drugs used to treat erectile dysfunction — Viagra, Levitra and Cialis — are safe and effective for men with diabetes, a new review has found.The introduction of the medications known as phosphodiesterase type 5 (PDE-5) inhibitors to the market has chang ed the way physicians manage their patients with erectile dysfunction. [click link for full article] (Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today) (more…)

Hair analysis to demonstrate administration of sildenafil to a woman in a case of drug-facilitated sexual assault. – Kintz P, Evans J, Villain M, Chatterton C, Cirimele V.

Monday, May 31st, 2010

The drug sildenafil (Viagra, Pfizer) and, more recently, tadalafil (Cialis, Lilly-Icos) and vardenafil (Levitra, Bayer), has drawn public attention to aphrodisiacs. The search for such substances dates back millennia. Adverse effects associated with these … (Source: SafetyLit: All (Unduplicated))

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 fre e advertising.

Newly-Published Data Showed LEVITRA(R) Treated Erectile Dysfunction Effectively At First Dose In Men With Certain Associated Cardiovascular Conditions

Sunday, May 30th, 2010

LEVITRA(R) (vardenafil HCl), is effective at first dose with continued success in treating erectile dysfunction (ED) in men with associated me dical conditions that affect the cardiovascular system. These conditions included high blood pressure, diabetes and/or dyslipidemia, which includes high cholesterol and other lipid abnormalities. [click link for full article] (Source: Health News from Medical News Today)

Viagra-Like Drugs Can Treat Erectile Dysfunction In Men With Diabetes

Sunday, May 30th, 2010

Around half of all men with diabetes have at least one episode during the course of their condition when they fail to maintain an erection sufficient for sexual intercourse. Many dif ferent strategies have been used to overcome this, but a Cochrane Review of clinical trials shows that three phosphodiesterase type 5 (PDE-5) inhibitors, sildenafil (Viagra), vardenafil (Levitra) and tadalafil (Cialis) increased diabetic men’s satisfaction with their (more…)

Levitra® – Opportunity for Proactive Generic Companies?

Sunday, May 30th, 2010

The recently released GenericsWeb Pipeline Developer patent report for Levitra® (Vardenafil) highlights the importance of high quality patent information when considering development of generic equivalents in the early stages of a product's lifecycle. (PRWeb Mar 26, 2007)

Post Comment:Trackback URL: http://www.prweb.com/zingpr.php/UGlnZy1FbXB0LU1hZ24tRmFsdS1NYWduLVplcm8= (Source: PRWeb: Medical Pharmaceuticals)

Most Medicare Prescription Drug Plans Will Drop Coverage For Erectile Dysfunction Medications In 2007

Sunday, May 30th, 2010

Most Medicare prescription drug plans in 2007 will not cover erectile dysfunction treatments such as Viagra, Cialis and Levitr a, the St. Louis Post-Dispatch reports. Many plans covered the treatments this year. According to the Post-Dispatch, “[m]any beneficiaries are learning of the change this week as they receive materials explaining next year’s benefits. [click link for full article] (Source: Health News from Medical News Today)

Schering-Plough, GlaxoSmithKline Study Further Validates MediSys Corporation’s MaxLife Center For Men(TM)

Sunday, May 30th, 2010

MediSysCorporation (Pink Sheets: MDYS) cited a recently published news release ofa study commissioned by SCHERING-PLOUGH and GLAXO SMITH KLINE, the makersof Levitra(R), that shows a cl ear indication that The MaxLife Center ForMen(TM) system has been — and continues to be — in the forefront of men’shealth. A national survey of U.S. [click link for full article] (Source: Cholesterol News From Medical News Today)

New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol

Sunday, May 30th, 2010

The first prospective trial specifically designed to evaluate erectile function in ED patients with dyslipidemia

CHICAGO, Dec. 10 (HSMN NewsFeed) — Results of the first prospective trial specifically designed to evaluate erectile function in erectile… BiopharmaceuticalsSchering-Plough, erectile dysfunction, LEVITRA, vardenafil, dyslipidemia (Source: HSMN NewsFeed)